News and Analysis
Innovation, Technology, and IP News
Fresh From the Bench: Latest Precedential Patent Case
CASE OF THE WEEK Medtronic, Inc. et al. v. Teleflex Innovations S.A.R.L., Appeal Nos. 2021-2356, -2358, -2361, -2363, and -2365 (Fed. Cir. May 24, 2023) In this week’s Case of...
ANDA Litigation: Navigating the Complexities of Patents and Generic Drug Approvals
In the world of pharmaceuticals, the Abbreviated New Drug Application (ANDA) process plays a critical role in the approval and market entry of generic drugs. However, the intersection...
FDA Approves Qalsody™ for Treatment of ALS
Written by: Douglas W. Crandell, Ph.D. & Robert J. Hilton, Ph.D. On April 25th, 2023, the U.S. Food and Drug Administration (FDA) approved QalsodyTM (tofersen) for the...
Brain Computer Interface Developer Announces $33M Series A, Granted FDA “Breakthrough” Designation
Written by:Tom Cowan Brain computer interface developer Paradromics on May 18, 2023, announced a $33 million Series A funding round as well as a...
Written by:Matthew Ruth & Philip M. Nelson
Going forward, medical device approval will require the device maker to provide... Read More »
In January, we delved into the intricacies of patent litigation in our third annual Patent Litigation Intelligence Report. This comprehensive study ... Read More »
CASE OF THE WEEK
Medtronic, Inc. et al. v. Teleflex Innovations S.A.R.L., Appeal Nos. 2021-2356, -2358, -2361, -2363, and -2365 (Fed... Read More »
In the world of pharmaceuticals, the Abbreviated New Drug Application (ANDA) process plays a critical role in the approval and market... Read More »
Written by: Douglas W. Crandell, Ph.D. & Robert J. Hilton, Ph.D.
On April 25th, 2023, the U.S. Food and Drug Administration (FDA)... Read More »
Written by:Tom Cowan
Brain computer interface developer Paradromics on May 18, 2023, announced a $33 million Series A... Read More »
Written by: Matthew Pham & Daniel P. Hughes
OneSubsea IP UK Limited v. FMC Technologies, Inc.
Before Clevenger, Moore, and ... Read More »
Written by: Matthew Friedrichs & Daniel P. Hughes
MEDTRONIC, INC. v. TELEFLEX INNOVATIONS S.A.R.L.
Before Moore, Lourie... Read More »
In today's digital landscape, protecting your trademarks has become more challenging than ever before. With the rise of e-commerce... Read More »
In the realm of patent examination, the search for prior art plays a critical role in determining the novelty and inventiveness of an... Read More »
Written by: Sophia Petrichenko & Jason J. Jardine
As predictions of an economic recession in the United States loom, 2023 has... Read More »
The recent judgment in Amgen v Sanofi by the United States Supreme Court has generated significant attention within the legal and patent... Read More »
Amgen Inc. et al. v. Sanofi et al, No. 21-757 (S. Ct. May 18, 2023)
The Supreme Court issued a long-awaited decision today concerning... Read More »
In the world of intellectual property, patents play a vital role in protecting inventions and encouraging innovation. However, disputes... Read More »
The Oncomouse patent stands as a remarkable milestone in the field of biotechnology patents, revolutionizing the way we approach... Read More »
CASE OF THE WEEK
Sanofi-Aventis Deutschland GmbH v. Mylan Pharmaceuticals Inc., Appeal No. 2021-1981 (Fed. Cir. May 9, 2023)... Read More »
Written by: Brittany M. Penn
DuPont announced on May 2, 2023 its acquisition of Spectrum Plastics... Read More »
In March, our fifth annual Patent Prosecution Intelligence Report was released, providing comprehensive coverage of the patent prosecution... Read More »
Written by:Nima Zargari, Ph.D. & Joseph Mallon, Ph.D.
On April 26, 2023, the European Commission proposed a pharmaceutical law... Read More »
SANOFI-AVENTIS DEUTSCHLAND GMBH V. MYLAN PHARMACEUTICALS INC.
Before Reyna, Mayer, and Cunningham. Appeal from Patent Trial and Appeal... Read More »
